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 Introduction 
The first edition of these Standards was published in 2013, summarizing the 
evidence of drug use prevention at the global level with a view to identify 
effective strategies, ensuring that children and youth, especially the most 
marginalized and poor, grow and stay healthy and safe into adulthood and old 
age. 
Member States and other national and international stakeholders recognised 
the value of this tool, with the Standards acknowledged multiple times as useful 
basis to improve the coverage and quality of evidence-based prevention.1 In 
addition, in 2015, the Member States of the United Nations made a series of 
wide-ranging commitments in the Sustainable Development Goals to be 
achieved by 2030 and Target 3.5 pledges to strengthen the prevention and 
treatment of substance abuse. In April 2016, the Special Session of the United 
Nations General Assembly on the world drug problem heralded a new era for 
addressing drug use and drug use disorders through a balanced and health-
centred system approach.  
In the context of this renewed emphasis on the health and wellbeing of people, 
UNODC and WHO are pleased to join forces and present this updated second 
edition. As in the case of the first edition, the Standards summarize the currently 
available scientific evidence on the basis of overview of recent systematic 
reviews, and describe interventions and policies that have been found to 
improve drug use prevention outcomes. In addition, the Standards identify the 
major components and features of an effective national prevention system. This 
work builds on, recognizes and is complementary to the work of many other 
organizations (e.g. EMCDDA, CCSA, CICAD, CP, NIDA 2 ) which have 
                                            
 
1 The Joint Ministerial Statement on the mid-term review of the implementation by Member 
States of the Political Declaration and Plan of Action; CND Resolution 57/3 - Promoting 
prevention of drug abuse based on scientific evidence as an investment in the well-being of 
children, adolescents, youth, families and communities; CND Resolution 58/3 - Promoting the 
protection of children and young people, with particular reference to the illicit sale and 
purchase of internationally or nationally controlled substances and of new psychoactive 
substances via the Internet; CND Resolution 58/7 - Strengthening cooperation with the 
scientific community, including academia, and promoting scientific research in drug demand 
and supply reduction policies in order to find effective solutions to various aspects of the world 
drug problem; CND Resolution 59/6 - Promoting prevention strategies and policies; Outcome 
Document of UNGASS 2016 on the World Drug Problem. 
2 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 
www.emcdda.europa.eu; Canadian Centre on Substance use (CCSA), www.ccsa.ca/Eng/; 
Inter-American Drug Abuse Control Commission (CICAD) at the Organization of the American 
States, http://cicad.oas.org/main/default_eng.asp; the Colombo Plan for Cooperative 
Economic and Social Development in Asia and the Pacific http://www.colombo-plan.org/; 
National Institute on Drug Abuse (NIDA), www.drugabuse.gov/.  
2 
developed other standards and guidelines on various aspects of drug use 
prevention.  
It is our hope that the Standards will continue to guide policy makers and other 
national stakeholders worldwide to develop programmes, policies and systems 
that are a truly effective investment in the future of children, youth, families and 
communities. 
1. Prevention is about the healthy and safe 
development of children 
Whilst the primary focus of the Standards is prevention of drug use, the 
approach of the document is holistic, taking into account the use of other 
psychoactive substances. With regard to the terminology as utilised in the 
Standards, the reader should consider that ‘drug use’ is used to refer to the use 
of psychoactive substances outside the framework of legitimate use for medical 
or scientific purposes in line with the three International Conventions 3 . 
‘Substance use’ is used to refer to the use of psychoactive substances 
regardless of their controlled status, including hazardous and harmful use of 
psychoactive substances. In addition to drug use, this includes the use of 
tobacco, alcohol, inhalants and new psychoactive substances (so-called ‘legal 
highs’ or ‘smart drugs’. 
For the purposes of this document, we considered the following primary 
objective of the prevention of the use of psychoactive substances: to help 
people, particularly but not exclusively of younger age, to avoid or delay the 
initiation of the use of psychoactive substances, or, if they have started already, 
to avert the development of substance use disorders (harmful substance use 
or dependence).  
The general aim of substance use prevention, however, is much broader than 
this: it is the healthy and safe development of children and youth to realize their 
talents and potential and becoming contributing members of their community 
and society. Effective prevention contributes significantly to the positive 
engagement of children, youth and adults with their families, schools, workplace 
and community.  
                                            
 
3 Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol; Convention 
on Psychotropic Substances of 1971; and United Nations Convention against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances of 1988. 
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Prevention science in the last 20 years has made enormous advances. As a 
result, practitioners in the field and policy makers have a more complete 
understanding about what makes individuals vulnerable to initiating the use of 
substances at both the individual and environmental level. The progression to 
disorders is also better understood.  
Lack of knowledge about substances and consequences of their use are among 
main factors increasing individuals’ vulnerability. Among other most powerful 
vulnerability factors are the following: genetic predisposition, personality traits 
(e.g. impulsivity, sensation seeking), the presence of mental and behavioural 
disorders, family neglect and abuse, poor attachment to school and the 
community, social norms and environments conducive to substance use 
(including the influence of media), and, growing up in marginalized and 
deprived communities. Conversely, psychological and emotional well-being, 
personal and social competence, a strong attachment to caring and effective 
parents, attachment to schools and communities that are well resourced and 
organized are all factors that contribute to individuals’ being less vulnerable to 
substance use and other risky behaviours. 
Some of the factors that make people vulnerable (or, conversely, resilient) to 
initiation of substance use differ according to age. Parenting and attachment to 
school are those vulnerability and resilience factors that have been identified 
during infancy, childhood and early adolescence. At later stages of the age 
continuum, schools, workplaces, entertainment venues, media are all settings 
that may contribute to making individuals more or less vulnerable to drug use 
and other risky behaviours.  
Needless to say, marginalized youth in poor communities with little or no family 
support and limited access to education in school, are especially at risk. So are 
children, individuals and communities torn by war or natural disasters. 
It is important to emphasize that the vulnerability factors referenced above are 
largely out of the control of the individual (nobody chooses to be neglected by 
his/her parents!) and are linked to many risky behaviours and related health 
conditions, such as dropping-out of school, aggressiveness, delinquency, 
violence, risky sexual behaviour, depression and suicide. It should not, 
therefore, come as a surprise that many drug prevention interventions and 
policies also prevent other risky behaviours. 
2. Prevention of psychoactive substance use 
In the case of controlled drugs, prevention is one of the main components of a 
health-centred system to address the non-medical use of these substances, as 
mandated by the existing three international Conventions. This document 
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focuses on prevention of the initiation of drug use and the prevention of 
transition to drug use disorders. These Standards do not address secondary 
and tertiary prevention interventions, including treatment of drug use disorders 
and the prevention of health and social consequences of drug use and drug 
use disorders, and the Standards do not address law enforcement efforts in 
drug control.  
It should be stressed that no effective prevention intervention, policy or system 
can be developed or implemented on its own, or in isolation. An effective local 
or national prevention system is embedded and integrated in the context of a 
larger health-centred and balanced system responding to drugs including law 
enforcement and supply reduction, treatment of drug use disorders, and 
reduction of risk associated with drug use (e.g. aimed at prevention of HIV, 
overdose, etc.). The overarching and main objective of such health-centred and 
balanced system would be to ensure the availability of controlled drugs for 
medical and scientific purposes whilst preventing diversion and non-medical 
use.  
Whilst the main focus of the Standards is the prevention of the use of drugs 
controlled in the three International Conventions (including also the non-
medical use of prescription drugs), the document draws upon the evidence and 
lessons accumulated in the field of prevention of other psychoactive substances, 
such as tobacco, alcohol and inhalants. Besides, the use of non-controlled 
psychoactive substances has a significant negative impact on population’s 
health. In fact, tobacco and alcohol use result in a higher burden of disease 
than disease burden attributable to the use of controlled drugs. Inhalants are 
extremely toxic with devastating consequences for psychosocial development 
and functioning, driving the urgent need for prevention efforts to address 
initiation of use. Moreover, in the case of children and adolescents, the brain is 
still developing and the earlier they start to use any psychoactive substance, 
the more likely they are to develop substance use disorders later in life. Last, 
but not the least, nicotine dependence and alcohol use disorders are very often 
associated with drug use and drug use disorders.  
3. Prevention science 
Thanks to prevention science, we also know a lot about what is effective in 
preventing substance use and what is not. The purpose of this document is to 
organize the findings from these years of research in a format that enhances 
the ability of policy makers to base their decisions on evidence and science. It 
is important to note that many of the limitations in the science that were 
identified during the first edition of the Standards are unfortunately still valid.  
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Most of the science originates from a handful of high-income countries in North 
America, Europe and Oceania. There are few studies from other cultural 
settings or in low- and middle-income countries. Moreover, most studies are 
‘efficacy’ studies that examine the impact of interventions in well-resourced, 
small, controlled settings. There are very few studies that have investigated the 
effectiveness of interventions in a ‘real life’ settings. Additionally, there are 
limited number of studies that have calculated whether interventions and 
prevention policy options are cost-beneficial or cost-effective (rather than just 
efficacious or effective). Finally, few studies report data disaggregated by sex. 
Another challenge suggests that often studies are too few to be able to 
conclusively identify ‘active ingredients’, i.e. the component or components that 
are really necessary for the intervention or policy to be efficacious or effective, 
also with regard to delivery of the strategies and interventions (who delivers 
them best? what qualities and training are necessary? what methods need to 
be employed? etc.).  
Finally, as in all medical, social and behavioural sciences, publication bias is a 
problem in prevention research. Studies which report new positive findings are 
more likely to be published than studies that report negative findings. This 
means that our analysis risks overestimating the efficacy and the effectiveness 
of substance use prevention interventions and policies. 
There is a strong and urgent need for research to be nurtured and supported in 
the field of substance use prevention globally. It is critical to support prevention 
research efforts in low- and middle-income countries, but national prevention 
systems in all countries should invest significantly in rigorous evaluation of their 
programmes and policies to contribute to the global knowledge base.  
What can be done in the meantime? Should policy makers wait for the gaps to 
be filled before implementing prevention initiatives? What can be done to 
prevent drug use and other psychoactive substance use, and ensure that 
children and youth grow healthy and safe now?  
The gaps in the science should make us cautious, but not deter us from action. 
A prevention approach that has been demonstrated to work in one area of the 
world is probably a better candidate for success than one that is created locally 
only on the basis of good will and guesswork. This is particularly the case for 
interventions and policies that address vulnerabilities that are significant across 
cultures (e.g. parental neglect). Moreover, approaches that have failed or even 
resulted in adverse effects in some countries are prime candidates for failure 
elsewhere. Prevention practitioners, policy makers and community members 
involved in drug prevention have a responsibility to take such lessons into 
consideration.  
What we have is an indication of where the right way lies. By using this 
knowledge and building on it with more evaluation and research, we can foster 
the development of national prevention systems that are based on scientific 
evidence and that will support children, youth and adults in different settings to 
lead positive, healthy and safe lifestyles. 
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4.  The International Standards 
This document describes the interventions and policies that have been found 
to be efficacious or effective by the scientific evidence in preventing substance 
use and could serve as the foundation of an effective health-centred national 
substance use prevention system. 
Throughout the document and for sake of simplicity, drug prevention endeavors 
are referred to as either ‘interventions’ or ‘policies’. An intervention refers to a 
group of activities of a specific kind. This could be a programme that is delivered 
in a specific setting in addition to the normal activities delivered in that setting 
(e.g. drug prevention education sessions in schools). However, the same 
activities could also be delivered as part of the normal functioning of the school 
(e.g. drug prevention education sessions as part of the normal health promotion 
curriculum). Normally, the evidence about most interventions has been derived 
from the evaluation of specific ‘programmes’, of which there can be many per 
intervention. For example, there are many programmes aiming at preventing 
drug use through the improvement of parenting skills (e.g. ‘Strengthening 
Families Program’, ‘Triple-P’, ‘Incredible Years’, etc.). These are different 
programmes delivering the same intervention (parenting skills/ family skills 
training). A policy refers to a regulatory approach either in a setting or in the 
general population. Examples include policies about substance use in schools 
or in the workplace or comprehensive restrictions or bans on the advertising of 
tobacco or alcohol. Finally, in the interest of brevity and of variation, sometimes 
the Standards use the term ‘strategies’ to refer to both interventions and policies 
together (i.e. a strategy can be either an intervention or a policy). 
The Standards also provide an indication as to how each strategy should be 
implemented, with common characteristics that have been found to be linked to 
efficacy and/or effectiveness. Finally, the document discusses how 
interventions and policies should exist in the context of national prevention 
systems supporting and sustaining their development, implementation, 
monitoring and evaluation on the basis of data and evidence. 
The process of updating of the International Standards 
The document has been created and published by UNODC and WHO with the 
assistance of a globally representative group of 143 researchers, policy makers, 
practitioners, representatives of non-governmental and international 
organizations from 47 countries. Most members of this “Group of Experts” were 
nominated by Member States, as they had all been invited to join the process. 
In addition, some were in part identified by UNODC because of their research 
and activities in the field of drug prevention.  
All members of the Group were requested to provide input both with regard to 
the methodology of updating the Standards, as well as on studies that might be 
of interest, in any language. In addition, a selection of the members of the Group 
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that had been most active met in June 2017 in Vienna, Austria to agree on the 
methodology for revision of the Standards. The methodology was subsequently 
finalised jointly by UNODC and WHO and is attached as “Appendix II Protocol 
for the overview of systematic reviews on interventions to prevent drug use for 
the second updated edition of the International Standards on Drug Use 
Prevention”.  
The evidence that forms the core of this update was identified through an 
overview of systematic reviews published between June 2012 and January 
2018 focusing on the primary outcomes of substance use prevention. Primary 
outcomes of prevention were defined as “initiation of substance use”, 
“continuation of substance use” and “progression to substance use disorders”.  
Aim of the search was to identify systematic reviews of the evidence studying 
the efficacy or effectiveness of interventions and/or policies with regard to 
preventing substance use (primary outcomes of prevention).  
Secondary outcomes of prevention (mediating factors or intermediate 
outcomes) were not included into the initial search strategy but were considered 
while consulting with experts, performing manual search and extraction of data 
from identified literature. Other references to the literature related to the 
secondary prevention outcomes had been identified during the development of 
the first edition of the Standards by expert advice.  
The search identified more than 28,800 items that were screened and reduced 
in number on the basis of the title first and then of the abstract.  
This was integrated with the studies identified by the members of the Group of 
Experts, as well as by manual searches of the Cochrane and Campbell 
databases. Such manual searches considered both the primary outcomes of 
substance use prevention and, in the case of strategies targeting children (10 
years of age and below) also secondary outcomes, i.e. mediating factors or 
intermediate outcomes of substance use prevention.  
To be included into the data extraction process studies had to be systematic 
reviews of primary studies (with or without meta-analysis) with a focus on 
substance use intervention(s) or policy(ies) that aim(s) at achieving outcomes 
in terms of prevention of substance use, or, if targeting children aged 10 or 
below, that aim(s) at achieving outcomes in terms of mediating factors related 
to substance use.  
Therefore, the following papers were excluded: epidemiological studies 
discussing prevalence, incidence, vulnerabilities and resilience linked to 
substance use; studies regarding treatment strategies or focusing only on the 
prevention of the health and social consequences of drug use and drug use 
disorders; primary studies; reviews of reviews; studies on the general delivery 
of prevention and/or prevention systems.  
Following a first screening based on both abstracts and full text, three hundred 
and ninety-two studies (392) were further reviewed for eligibility. The full list of 
392 papers is provided in Appendix I. Two hundred and two studies were found 
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to be eligible and were assessed for the risk of bias using the Risk of Bias in 
Systematic Reviews (ROBIS) tool4 . Data was extracted only from reviews 
reporting low risk of bias (71 reviews). Appendix I provides a separate list of 
these reviews and the flow diagram of the review process is presented in 
Appendix III.  
In addition, these 71 reviews were integrated with the reviews from the first 
edition of the Standards, provided there was no more recent equivalent study 
identified through the current search. The data extraction table (“Appendix IV 
Summary of Results”) reported all the conclusions included in the studies and 
served as the basis for the update of the summary of the evidence under each 
strategy.  
The process was further enriched by the utilization of existing WHO guidance 
providing recommendations on the use of various interventions and policies to 
prevent substance use, but also other risky behaviours (e.g. violence) or to 
promote the healthy development of children and youth. Existing WHO 
guidance, when available, is summarised under each strategy following the 
summary of the evidence based on the data extraction.  
Under each strategy the Standards also list, to the extent possible, the 
characteristics of the strategies that are associated with efficacy and/or 
effectiveness, or lack thereof. These characteristics were largely identified 
through expert advice during the development of the first edition of the 
Standards and have been only marginally edited, following comments by the 
Group of Experts to the first draft of this second updated edition. The final 
chapter on national prevention systems had also been drafted on the basis of 
expert advice and has been updated on the basis of comments from the Group 
of Experts.  
Limitations 
There is a number of limitations that need to be acknowledged while using this 
document. First, the overall searching strategy aimed to capture evidence 
related to as many potential interventions as possible, instead of being focused 
on details of each specific intervention. Therefore, it is expected that the search 
strategy could miss literature sources and important details related to particular 
interventions as it would require more detailed and narrow search strategy.  
Secondly, the literature search was focused on primary outcomes only 
(substance use) and did not systematically review evidence on secondary 
outcomes (i.e. mediating factors of prevention). Therefore, the Standards do 
                                            
 
4 Whiting, P., et al., ROBIS: A new tool to assess risk of bias in systematic reviews was 
developed. J Clin Epidemiol, 2015. 
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not address comprehensively the issue of mediating factors of substance use 
prevention.  
Finally, although the risk of bias of research was evaluated using ROBIS, the 
grading of the evidence was not undertaken. Similarly, the analysis of 
interventions from other perspectives beyond effectiveness (e.g. analysis of 
harms and benefits, cost-effectiveness, values and preferences, equity, gender 
balance, human rights etc.) was also not undertaken. Therefore, due to above-
listed limitations the Standards do not include formal recommendations. The 
Standards present a summary of the results identified through the overview of 
systematic reviews and, where possible, it was strengthened by extractions 
from available international guidelines to cover additional issues and present 
more details. 
The document 
The document is comprised of three chapters. Chapter I describes the 
interventions and policies that have been found to be efficacious and/or 
effective in preventing drug use and other psychoactive substance use.  
Interventions and policies are grouped by the age of the target group, 
representing a major developmental stage in the life of an individual: pregnancy, 
infancy and early childhood; middle childhood; early adolescence; adolescence 
and adulthood. 
Every child is unique and his or her development will be also influenced by a 
range of socio-, economic and cultural factors. That is why, the ranges referred 
to by the different ages have not been defined numerically. However, as a 
general guide, and for the purposes of this document, the following could be 
considered: infancy and early childhood refer to pre-school children, mostly 0-
5 years of age; middle childhood refers to primary school children, 
approximately 6-10 years of age; early adolescence refers to middle school or 
junior high school years, 11-14; adolescence refers to senior high school, late 
teen years: 15 to 18/19 years of age; adulthood refers to subsequent years. 
Although the range has not been used in the Standards for reasons of 
expediency, young adulthood (college or university years, 20-25 years of age) 
is also sometimes referred to, as it is used in many studies. 
Some interventions and policies are relevant for more than one age group. In 
this case, the description is not repeated. They are included under the age for 
which they are most relevant with a reference to the other developmental stages 
for which there is also available evidence. 
The section on each strategy includes, to the extent possible, the following 
details: a brief description; the available evidence; and, the characteristics that 
appear to be linked to with efficacy and/or effectiveness, or lack thereof. 
Brief description: This sub-section briefly describes the intervention or the policy, 
its main activities and theoretical basis. Moreover, it includes an indication of 
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whether the strategy is appropriate for the population at large (universal 
prevention), or for population groups with the risk significantly above the 
average (selective prevention), or for individuals that are particularly at risk 
(indicated prevention, which also includes individuals that might have started 
experimenting and are therefore at particular risk of progressing to disorders). 
In addition, the Standards illustrate whether the strategy includes environmental 
and/or development and/or information components.  
Available evidence: This is the core of Standards. The text describes what the 
available evidence is and the findings reported in it. Effects on primary 
outcomes (substance use) are reported first, with effects on secondary 
outcomes of prevention (i.e. mediating factors/ intermediate outcomes of 
prevention) reported subsequently and separately. Wherever available, effect 
sizes are included, as provided in the original studies, as well as different effects 
with regard to different target groups and the sustainability of the effects. The 
geographical source of the evidence is indicated to offer policy makers and 
prevention program managers an indication of whether it is already known that 
a strategy is effective in different geographical settings. Finally, if there is an 
indication of cost-effectiveness, this is also included in these paragraphs. This 
part of the text is based on the studies included in data extraction or taken from 
previous edition, as mentioned above. A second box provides, wherever 
available, WHO guidance on the effectiveness of the strategies with regard to 
substance use or other health outcomes as presented in the published WHO 
guiding documents.  
Characteristics linked to with efficacy and/or effectiveness, or lack thereof: The 
document also provides an indication of characteristics that have been found 
by the Group of Experts to be linked to efficacy and/or effectiveness, or where 
available, to ineffectiveness or even adverse effects. These indications should 
not be taken to imply a relation of cause and effect. As noted above, there is 
not enough evidence to allow for this kind of analysis. Rather, the intention is to 
suggest the direction that is likely to bring more chances of success according 
to the collective research and practical experience of the Group of Experts. All 
strategies should be undertaken in a research environment, applying protocols 
found to be effective in preventing drug use and addressing vulnerability and 
resilience factors.  
Chapter II briefly describes prevention issues where further research is 
particularly required. This includes interventions and policies for which no 
evidence was found, but also emerging substance use problems, as well as 
particularly vulnerable groups. Wherever possible, a brief discussion of 
potential strategies is provided.  
The third and final Chapter describes the possible components for an effective 
national prevention system building on evidence-based interventions and 
policies and aiming at the healthy and safe development of children and youth. 
This is another area where further research is urgently needed, as 
investigations have traditionally focused more on the effectiveness of single 
interventions and policies. As mentioned above, the drafting of this Section 
benefited from the expertise and the consensus of the Group of Experts.  
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I. Drug prevention interventions 
and policies 
1. Infancy and early childhood 
Children’s earliest interactions occur in the family before they reach school. 
They may develop vulnerabilities when they experience interaction with parents 
or caregivers who fail to nurture and/or lack parenting skills and/or suffer from 
other difficulties associated with poor health, financial or other hardships 
(especially in a socio-economically marginalised environment or a dysfunctional 
family setting). Among other factors, the intake of alcohol, nicotine, and drugs 
during pregnancy negatively affect developing embryos and foetuses.  
Such circumstances may impede reaching significant developmental 
competencies and make a child vulnerable and at risk for behavioural disorders 
later on. The key developmental goals for early childhood are the development 
of safe attachment to the caregivers, age-appropriate language skills, and 
executive cognitive functions such as self-regulation and pro-social attitudes 
and skills. The acquisition of these is best supported within the context of a 
supportive family and community. 
Prenatal and infancy visitation 
Brief description 
In these programmes, a trained nurse or social worker visits mothers-to-be and 
new mothers to provide them with parenting skills and support in addressing a 
range of issues (health, housing, employment, legal, etc.). Normally, these 
programmes do not target all women, but only some specific groups living in 
difficult circumstances compared to the general population (selective strategy 
with a developmental aim). 
Available evidence 
No new reviews were identified in the new overview of systematic reviews.  
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In the first edition, one review and one randomized control trial had reported 
findings with regard to this intervention5.  
With regard to primary outcomes, according to the randomized controlled trial, 
these programmes can prevent substance use later in life and they can also be 
cost-effective in terms of saving future social welfare and medical costs.  
In addition, a review reported findings with regard to some secondary 
outcomes, with children within the programme less likely to report having 
internalizing disorders, as well as scoring higher on the achievement tests in 
reading and math. Mothers taking part in the programme also reported less role 
impairment owing to alcohol and other drug use. The evidence originates from 
the USA.  
Prenatal and infancy visitation programmes are also recommended by WHO to 
prevent child maltreatment6. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Delivered by trained health workers; 
 Regular visits up to two years of age of the baby, at first every two weeks, 
then every month and less towards the end; 
 Provision of basic parenting skills; 
 Supporting mothers to address a range of socio-economic issues (health, 
housing, employment, legal, etc.). 
Interventions targeting pregnant women  
Brief Description 
Pregnancy and motherhood are periods of major and sometimes stressful 
changes that may make women receptive to address their substance use and 
substance use disorders.  
                                            
 
5 Turnbull (2012), with Kitzman (2010) and Olds (2010) reporting on the same trial.  
6 WHO (2016), INSPIRE: seven strategies for ending violence against children. 
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Alcohol and drug use during pregnancy poses potential health risks to pregnant 
women themselves and to their babies, even in the absence of substance use 
disorders. All pregnant women should therefore be advised of the potential 
health risks to themselves and to their babies. As psychoactive substance use 
during pregnancy is dangerous for the mother and for the future child, 
management of substance use and treatment of pregnant women with 
substance use disorders can and should be offered as a priority and must follow 
rigorous clinical guidelines based on scientific evidence. This is an indicated 
strategy with a developmental aim.  
Available evidence 
No new reviews were identified in the new overview of systematic reviews.  
In the first edition, two reviews had reported findings with regard to this 
intervention7.  
No reviews reported findings with regard to primary outcomes. 
With regard to secondary outcomes, providing evidence-based integrated 
treatment to pregnant women can have a positive impact on child development, 
child emotional and behavioural functioning and parenting skills.  
The time frame for the sustainability of these results and the origin of the 
evidence are not clear. 
WHO guidelines include the following recommendations about substance use 
during pregnancy: 
Tobacco use:  
Health-care providers should ask all pregnant women about their tobacco use 
(past and present) and exposure to second-hand smoke as early as possible in 
the pregnancy and at every antenatal care visit8. 
Substance use:   
Health-care providers should ask all pregnant women about their use of alcohol 
and other substances (past and present) as early as possible in the pregnancy 
and at every antenatal care visit.  
                                            
 
7 Niccols (2012a) and Niccols (2012b). 
8 WHO recommendations for the prevention and management of tobacco use and second-
hand smoke exposure in pregnancy 
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Health-care providers should offer a brief intervention to all pregnant women 
using alcohol or drugs. 
Health-care providers managing pregnant or postpartum women with alcohol 
or other substance use disorders should offer comprehensive assessment and 
individualized care. 
Health-care providers should, at the earliest opportunity, advise pregnant 
women dependent on alcohol or drugs to cease their alcohol or drug use and 
offer, or refer to, detoxification services under medical supervision where 
necessary and applicable. 
For more detailed recommendations on the management of particular clinical 
situations in pregnancy (e.g. opioid dependence, benzodiazepine dependence, 
etc.), the reader is referred to the WHO Guidelines for identification and 
management of substance use and substance use disorders in pregnancy9.  
Early childhood education 
Short description 
Early childhood education programmes supports the social and cognitive 
development of pre-school children (2 to 5 years of age) from deprived 
communities. It is therefore a selective level intervention with developmental 
content.  
Available evidence 
No new reviews were identified in the new overview of systematic reviews.  
In the first edition, two reviews had reported findings with regard to this 
intervention10.  
According to these studies, offering early education services to the children 
growing in disadvantaged communities can reduce marijuana use at age 18 
and can also decrease the use of tobacco and other drugs (primary outcomes).  
                                            
 
9 WHO (2014), WHO Guidelines for identification and management of substance use and 
substance use disorders in pregnancy. 
10 D’Onise, 2010 and Jones 2006. 
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With regard to secondary outcomes, early education can prevent other risky 
behaviours and support mental health, social inclusion and academic success.  
All evidence originates from the USA. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Improving the cognitive, social and language skills of children; 
 Daily sessions; 
 Delivered by trained teachers; 
 Provision of support to families on other socio-economic issues. 
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2. Middle childhood 
During middle childhood, increasingly more time is spent away from the family, 
most often in school and with same age peers. Family still remains the key 
socialization agent. However, the role of day-care, school, and peer groups 
start to grow. In this respect, factors such as community norms, school culture 
and quality of education become increasingly important for safe and healthy 
emotional, cognitive, and social development. The role of social skills and 
prosocial attitudes grows in middle childhood and they become key protective 
factors, impacting also the extent to which the school-aged child will cope and 
bond with school and peers. 
Among the main developmental goals in middle childhood are the continued 
development of age specific language and numeracy skills, and of impulse 
control and self-control. The development of goal directed behaviour, together 
with decision-making and problem-solving skills, starts. Mental disorders that 
have their onset during this time period (such as anxiety disorders, attention 
deficit hyperactivity disorder, conduct disorders) may also impede the 
development of healthy attachment to school, cooperative play with peers, 
adaptive learning, and self-regulation. Children of dysfunctional families often 
start to affiliate at this time with peers involved in potentially harmful behaviours, 
thus putting themselves at increased risk.  
Parenting skills programmes 
Short description 
Parenting skills programmes support parents in being better parents, in very 
simple ways. A warm child-rearing style, where parents set rules for acceptable 
behaviours, closely monitor free time and friendship patterns, help to acquire 
personal and social skills, and are role models is one of the most powerful 
protective factors against substance use and other risky behaviours. These 
programmes can be delivered also for parents of early adolescents. As the 
reviews largely cover all ages together, and as principles are largely similar, the 
interventions are only discussed here. These interventions can be delivered 
both at the universal and at the selective level and are largely a developmental 
kind of intervention. 
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Available evidence 
Five (5) reviews reported findings with regard to this intervention, of which four 
(4) are from the new overview of systematic reviews11. 
With regard to primary outcomes, these studies report that family-based 
universal programmes can prevent tobacco, alcohol, drug and substance use 
in young people, the effect size being generally persistent into the medium and 
long term (more than 12 months).  
More intensive programmes delivered by a trained facilitator appear to be more 
consistently effective compared to single sessions or computer-based 
programmes. Also, particular gender-specific interventions targeting mothers 
and daughters reported effectiveness. 
The evidence summarized above originates from studies on family-based 
prevention interventions implemented in Africa, Asia, Middle East, Europe, 
Australia and North America. 
Parenting skills programme are also recommended by WHO to support positive 
development, prevent youth violence, manage behavioural disorders in children 
and adolescents12, and prevent child maltreatment13.  
Parenting interventions promoting mother-infant interactions preferably 
delivered within ongoing mother and child health programmes for poorly 
nourished, frequently ill and other groups of at risk children are also 
recommended to improve child development outcomes14. 
Moreover, improving mothers’ parenting skills is recommended to be offered in 
addition to effective treatment and psychosocial support to mothers with 
depression or with any other mental, neurological or substance use condition 
in order to improve child development outcomes15.  
                                            
 
11 Mejia (2012), Thomas et al. (2016), Foxcroft and Tsertsvadze (2012), Allen et al. (2016), 
Kuntsche (2016). 
12 WHO (2017), Global Accelerated Action for the Health of Adolescents (AA-HA!), Guidance 
to Support Country Implementation 
13 WHO (2016), INSPIRE: seven strategies for ending violence against children. 
14 WHO (2012), Maternal mental health interventions to improve child development, Evidence 
profile.  
15 WHO (2012), Maternal mental health interventions to improve child development, Evidence 
profile. 
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Finally, caregiver skills training should be provided for management of children 
and adolescents with developmental disorders, including intellectual disabilities 
and pervasive developmental disorders (including autism)16.  
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Enhance family bonding, i.e. the attachment between parents and children; 
 Support parents on how to take a more active role in their children’s lives, 
e.g., monitoring their activities and friendships, and being involved in their 
learning and education; 
 Support parents on how to provide positive and developmentally appropriate 
discipline; 
 Support parents on how to be a role model for their children. 
 Organised in a way to make it easy and appealing for parents to participate 
(e.g. out-of-office hours, meals, child care, transportation, small prize for 
completing the sessions, etc.); 
 Typically include a series of sessions (often around 10 sessions, more in 
the case of work with parents from marginalised or deprived communities or 
in the context of a treatment programme where one or both parents suffer 
from substance use disorders); 
 Typically include activities for the parents, the children and the whole family; 
 Delivered by trained individuals, in many cases without any other formal 
qualification. 
Characteristics deemed to be associated with lack of efficacy and/or 
effectiveness or with adverse effects based on expert consultation 
 Undermine parents’ authority; 
 Only provide information to parents about drugs so that they can talk about 
it with their children; 
 Delivered by poorly trained staff.  
                                            
 
16 WHO (2012), Maternal mental health interventions to improve child development, Evidence 
profile. 
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Existing guidelines and tools for further information 
 Universal Prevention Curriculum, Coordinator Series, Course 4: Family-
based Prevention Interventions (2015) 
 UNODC (2010), Compilation of Evidence-Based Family Skills Training 
Programmes, United Nations Office on Drugs and Crime, Vienna, Austria. 
 CCSA (2011), Strengthening Our Skills: Canadian guidelines for youth 
substance use prevention family skills programs, Canadian Centre on 
Substance use, Ottawa, ON, Canada. 
 UNODC (2009), Guide to implementing family skills training programmes for 
drug abuse prevention, United Nations Office on Drugs and Crime, Vienna, 
Austria. 
 WHO Mental Health Gap Action Programme (mhGAP) Evidence-based 
recommendations for management of child and adolescent mental disorders 
in non-specialized health settings. 
Personal and social skills education  
Description 
During these programmes, trained teachers engage children in interactive 
activities to give them the opportunity to learn and practice a range of personal 
and social skills. These programmes are typically delivered to all children via 
series of structured sessions (i.e. this is a universal level intervention). The 
programmes provide opportunities to learn skills to be able to cope with difficult 
situations in the daily life in a safe and healthy way. They support the 
development of general social competencies, including mental and emotional 
wellbeing. These programmes comprise mostly of developmental components, 
i.e. they do not typically include content with regard to specific substances, as 
in most communities children at this young age have not initiated use. This is 
not the case everywhere and programmes targeting children who have been 
exposed to substances (e.g. inhalants) at this very young age might want to 
refer to the substance specific guidance included for “Prevention education 
based on personal and social skills and social influence” under “Early 
adolescence”.  
20 
Available evidence 
Seven (7) reviews reported findings with regard to this intervention, four (4) of 
which from the new overview17.  
With regard to primary outcomes, according to these studies, supporting the 
development of personal and social skills in a classroom setting can prevent 
tobacco, alcohol and drug use, particularly at a longer follow-up (more than one 
year). The effectiveness of strategies focusing only on resilience was limited to 
drug use.  
Most of the evidence originates from North America, Europe and Australia, with 
some studies from Asia and Africa.  
Non-specialized health care facilities should encourage and collaborate with 
school-based life skills education, if feasible, to promote mental health in 
children and adolescents18. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Improves a range of personal and social skills; 
 Delivered through a series of structured sessions, often providing boosters 
sessions over multiple years; 
 Delivered by trained teachers or facilitators;  
 Sessions are primarily interactive. 
Characteristics deemed to be associated with lack of efficacy and/or 
effectiveness or with adverse effects based on expert consultation 
 Using non-interactive methods, such as lecturing, as main delivery method;  
 Providing information on specific substances, including fear arousal. 
 Focus only on the building of self-esteem and on emotional education. 
                                            
 
17 Hodder et al. (2017), Salvo et al. (2012), McLellan & Perera (2013), McLellan & Perera 
(2015), Schröer-Günther (2011), Skara (2003).  
18 WHO (2012), WHO Mental Health Gap Action Programme (mhGAP) Behaviour change 
techniques for promoting mental health, Evidence profile 
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Existing guidelines and tools for further information 
 UNESCO/ UNODC/ WHO (2016), Good Policy and Practice in Health 
Education: Education sector responses to the use of alcohol, tobacco and 
drugs 
 Universal Prevention Curriculum, Coordinator Series, Course 5: School-
based Prevention Interventions (2015) 
 CICAD Hemispheric Guidelines on School Based Prevention 
 Canadian Standards for School-based Youth Substance Use Prevention 
 WHO Mental Health Gap Action Programme (mhGAP) Evidence-based 
recommendations for management of child and adolescent mental disorders 
in non-specialized health settings 
Classroom environment improvement programmes 
Brief description 
These programmes strengthen the classroom management abilities of teachers, 
and support children to socialize in their role as a student, whilst reducing early 
aggressive and disruptive behaviours. Teachers are typically supported to 
implement a collection of non-instructional classroom procedures in the day-to-
day practices with all students for the purposes of teaching prosocial behaviour 
as well as preventing and reducing inappropriate behaviour. These 
programmes facilitate both academic and socio-emotional learning. They are 
universal as they target the whole class with a developmental component.  
Available evidence 
No new reviews were identified in the new overview of systematic reviews.  
In the first edition, one review had reported findings with regard to this 
intervention19.  
The review did not report findings with regard to the primary outcomes.  
With regard to secondary outcomes, according to this study, teachers' 
classroom management practices significantly decrease problem behaviour in 
                                            
 
19 Oliver, 2011. 
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the classroom, including strong effects on disruptive and aggressive behaviour 
and strengthen the pro-social behaviour and the academic performance of the 
children. The time frame for the sustainability of these results is not clear.  
All evidence reported above originates from the USA and Europe. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Often delivered during the first school years; 
 Include strategies to respond to inappropriate behaviour;  
 Include strategies to acknowledge appropriate behaviour; 
 Include feedback on expectations;  
 Active engagement of students. 
Policies to retain children in school 
Brief description 
School attendance, attachment to school, and the achievement of age-
appropriate language and numeracy skills are important protective factors for 
substance use among children of this age. A variety of policies has been 
implemented in low- and middle-income countries to support the attendance of 
children and improve their educational outcomes. 
Available evidence 
No new reviews were identified in the new overview of systematic reviews.  
In the first edition, two reviews20 reported findings with regard to the following 
policies: building new schools, providing nutrition in schools and providing 
economic incentives of various natures to families.  
The studies did not report findings with regard to the primary outcomes.  
                                            
 
20 Lucas (2008) and Petrosino (2012). 
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With regard to secondary outcomes, according to these studies, these policies 
increase the attendance of children in school, and improve their language and 
numeracy skills. Providing simple cash to families does not appear to result in 
significant outcomes, while conditional transfers do. The time frame for the 
sustainability of these results is not clear.  
All this evidence originates from low- and middle-income countries.  
Conditional financial incentives to keep children in schools are also 
recommended by WHO as a strategy to prevent youth violence21. 
Addressing mental health disorders 
Brief description 
Emotional disorders (e.g. anxiety, depression) and behavioural disorders (e.g. 
ADHD, conduct disorder) are associated with higher risk of substance use later 
in adolescence and in life. In both childhood and adolescence, supporting 
children, adolescents and parents to address emotional and behavioural 
disorders as early as possible is an important prevention strategy.  
Available evidence 
No studies were identified either in the new overview of systematic reviews or 
in the first edition of the Standards. 
WHO recommends the following to support children and adolescents (as well 
as their carers) and to address such disorders as early as possible22: 
Behavioural interventions for children and adolescents for the treatment of 
behavioural disorders. 
                                            
 
21 WHO (2017), Global Accelerated Action for the Health of Adolescents (AA-HA!) Guidance 
to Support Country Implementation. 
22 WHO (2016), mhGAP Intervention Guide for mental, neurological and substance use 
disorders in non-specialized health settings. Version 2.0. WHO, 2016. 
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Psychological interventions, such as cognitive behavioural therapy (CBT), 
interpersonal psychotherapy (IPT) for children and adolescents with emotional 
disorders, and caregiver skills training focused on their caregivers.  
Initiating parent education/training before starting medication for a child who 
has been diagnosed as suffering from attention-deficit hyperactivity disorder 
(ADHD), with initial interventions including cognitive-behavioural therapy and 
social skills training if feasible. 
Offering pharmacological interventions only in specialised settings.  
Existing guidelines and tools for further information 
 The WHO Mental Health Gap Action Programme (mhGAP) intervention 
guide and training manuals (WHO, 2016).  
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3. Early adolescence 
Adolescence is a developmental period when youth are exposed to new ideas 
and behaviours through increased associations with people and organizations 
beyond those experienced in childhood. It is a time to “try out” adult roles and 
responsibilities. It is also a time when the “plasticity” and malleability of the 
adolescent brain suggests that, like infancy, this period of development is a time 
when interventions can reinforce or alter earlier experiences.  
The desire to assume adult roles and more independence at a time when 
significant changes are occurring in the adolescent brain also creates a 
potentially opportune time for poorly thought out decisions and involvement in 
potentially harmful behaviours, such as risky sexual behaviours, smoking of 
tobacco, consumption of alcohol, risky driving behaviours, and drug use.  
The substance use (or other potentially harmful behaviours) of peers, as well 
as rejection by peers, are important influences on behaviour, although the 
influence of parents still remains significant. Healthy attitudes and social 
normative beliefs related to psychoactive substance use are also important 
protective factors against drug use. Good social skills, and resilient mental and 
emotional health remain key protective factors throughout adolescence. 
PLEASE NOTE. Parenting skills interventions can be implemented in middle 
childhood and early adolescence. The studies identified through the research 
do not disaggregate results by age. Therefore, rather than repeating the section 
on parenting skills here, under ‘Early adolescence’, the reader is referred to the 
previous section. The same applies to the section on ‘Addressing mental health 
disorders’. Similarly, many of the interventions and policies of relevance to older 
adolescents can prevent substance use in early adolescence. For reasons of 
expediency, they are discussed only in the next session. This applies to: alcohol 
and tobacco policies, media campaigns, brief intervention and community-
based multi-component initiatives.  
Prevention education based on social competence and influence  
Brief description 
During skills based prevention programs, trained teachers engage students in 
interactive activities to give them the opportunity to learn and practice a range 
of personal and social skills (social competence). These programs focus on 
fostering substance and peer refusal abilities that allow young people to counter 
social pressures to use substances and in general cope with challenging life 
situations in a healthy way.  
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In addition, they provide the opportunity to discuss in an age appropriate way, 
the different social norms, attitudes and positive and negative expectations 
associated with substance use, including the consequences of substance use. 
They also aim to change normative beliefs on substance use addressing the 
typical prevalence and social acceptability of substance use among the peers 
(social influence).  
Available evidence 
Twenty-two (22) reviews reported results for this kind of intervention23, fifteen 
(15) of which from the new overview.  
With regard to primary outcomes, according to these studies, certain 
programmes based on a combination of a social competence and social 
influence prevent tobacco use, alcohol use and drug use (preventive effects are 
small, but consistent across studies, also in the long term (+12 months)).  
A review of school-based prevention of smoking specifically for girls concluded 
that there is no evidence that school-based smoking prevention programs have 
a significant effect on preventing adolescent girls from smoking, with some 
promising indication for gender-specific programmes and programmes 
delivered together with media campaigns.  
Programmes targeting individual and environmental resilience-related 
protective factors in school settings were reported to be effective in preventing 
the use of drugs, but not of tobacco or alcohol. Programmes based on the 
provision of information only, as well as the programme “Drug Abuse 
Resistance Education (D.A.R.E.)”, were reported not to be effective. 
Peers were reported to be effective in delivering programmes for all 
substances, with the caveat that care should be taken for this not to happen 
amongst high risk groups, as there is a danger of adverse effects (e.g. increase 
of substance use). Computer based delivery methods generally reported small 
effect size for all substances. 
In this context, there are indications that programs targeting early adolescents 
might better prevent substance use than programs targeting younger or older 
children. Most evidence is on universal programs, but there are indications that 
universal skills based education may be preventive also among high-risk 
groups, including youth with mental health disorders.  
                                            
 
23 Ashton et al. (2015), Champion (2013), de Kleijn et al. (2015), Espada et al. (2015), 
Faggiano et al. (2014), Foxcroft & Tsertsvadze (2012), Hale et al. (2014), Hodder et al. 
(2017), Jackson (2012), Jones (2006), Kezelman & Howe (2013), Lee et al. (2016), McArthur 
et al. (2015), McLellan & Perera (2013), McLellan & Perera (2015), Pan (2009), Roe (2005), 
Salvo et al. (2012), Schröer-Günther (2011), West (2004). 
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Whilst most of the evidence originates from North America, Europe and 
Australia, some studies originated from Asia and Africa.  
Programmes including also a social and emotional learning component are also 
recommended by WHO to prevent youth violence24. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Use interactive methods; 
 Delivered through a series of structured sessions (typically 10-15) once a 
week, often providing boosters sessions over multiple years; 
 Delivered by trained facilitator (including also trained peers); 
 Provide opportunity to practice and learn a wide array of personal and social 
skills, including particularly coping, decision making and resistance skills, 
and particularly in relation to substance use; 
 Impact perceptions of risks associated with substance use, emphasizing 
immediate consequences; 
 Dispel misconceptions regarding the normative nature and the expectations 
linked to substance use. 
Characteristics deemed to be associated with lack of efficacy and/or 
effectiveness or with adverse effects based on expert consultation 
 Utilise non-interactive methods, such as lecturing, as a primary delivery 
strategy; 
 Information-giving alone, particularly fear arousal. 
 Based on unstructured dialogue sessions; 
 Focus only on the building of self-esteem and emotional education; 
 Address only ethical/ moral decision making or values; 
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to Support Country Implementation. 
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 Use ex-drug users as testimonials. 
Existing guidelines and tools for further information 
 UNESCO/ UNODC/ WHO (2016), Good Policy and Practice in Health 
Education: Education sector responses to the use of alcohol, tobacco and 
drugs 
 Universal Prevention Curriculum, Coordinator Series, Course 5: School-
based Prevention Interventions (2015) 
 CICAD Hemispheric Guidelines on School Based Prevention 
 Canadian Standards for School-based Youth Substance Use Prevention 
School policies on substance use 
Brief description 
School policies on substance use mandate that substances should not be used 
on school premises and during school functions and activities by both students 
and staff. Policies also create transparent and non-punitive mechanisms to 
address incidents of use transforming it into an educational and health 
promoting opportunity. These interventions and policies are universal, but may 
include also indicated components such as screening, brief interventions and 
referral. They are often implemented jointly with other prevention interventions, 
such as skills based education and/or school-wide policies to promote school 
attachment and/or supporting parenting skills and parental involvement. 
Available evidence 
Four reviews reported findings for these interventions25, three of which from the 
new overview. Three of the reviews studied tobacco policies in schools, and 
one interventions in tertiary education settings (colleges and universities).  
With regard to primary outcomes, the three reviews on tobacco policies, 
including one on school-based incentives for tobacco prevention, reported 
different results, with few studies reporting evidence of effectiveness and more 
than half reporting no evidence of effect. The studies providing findings did find 
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a lower probability of tobacco smoking in schools with a smoking ban and a 
higher probability in schools with more liberal attitudes. There was some 
evidence that the formality of the policy (e.g. written policy) and its enforcement 
also had an additional impact on smoking behaviour.  
In colleges and universities, some environmental interventions, social norms 
marketing campaigns, and cognitive–behavioural/ skill-based interventions 
might have benefits with regard to prevention of harmful use of alcohol, with the 
strongest evidence for brief motivational interventions and for personalized 
normative interventions (both computer and face-to-face).  
Although most evidence originates from North America, Europe and Australia/ 
New Zealand, there is also evidence originating from Asia. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Support normal school functioning, not disruption; 
 Policies developed with the involvement of all stakeholders (students, 
teachers, staff, parents); 
 Policies clearly specify the substances that are targeted, as well as the 
locations (school-premises) and/or occasions (school functions) the policy 
applies to; 
 Apply to all in the school (student, teachers, staff, visitors, etc.) and to all 
psychoactive substances (tobacco, alcohol, drugs); 
 Address infractions of policies with positive sanctions by providing or 
referring to counselling, treatment and other health care and psycho-social 
services rather than punishing; 
 Enforce consistently and promptly, including positive reinforcement for 
policy compliance. 
Characteristics deemed to be associated with lack of efficacy and/or 
effectiveness or with adverse effects based on expert consultation 
 Inclusion of random drug testing.  
Existing guidelines and tools for further information 
 UNESCO/ UNODC/ WHO (2016), Good Policy and Practice in Health 
Education: Education sector responses to the use of alcohol, tobacco and 
drugs 
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 Universal Prevention Curriculum, Coordinator Series, Course 5: School-
based Prevention Interventions (2015) 
 CICAD Hemispheric Guidelines on School Based Prevention 
 Canadian Standards for School-based Youth Substance Use Prevention 
School-wide programmes to enhance school attachment 
Brief description 
School-wide programmes to enhance school attachment support student 
participation, positive bonding and commitment to school. These interventions 
and policies are universal. They are often implemented jointly with other 
prevention interventions, such as skills based education and/or school policies 
on substance use and/or supporting parenting skills and parental involvement. 
Available evidence 
Two reviews reported findings for this intervention26, one of which from the new 
overview.  
With regard to the primary outcomes, one study reported that these strategies 
contribute to preventing use of all substances, with another study reporting 
results only for drug use and not significant results for tobacco and alcohol. 
Although most evidence originates from North America, Europe and Australia/ 
New Zealand, there is also evidence originating from Asia. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Support positive school ethos and commitment to school; 
 Support student participation. 
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Existing guidelines and tools for further information 
 UNESCO/ UNODC/ WHO (2016), Good Policy and Practice in Health 
Education: Education sector responses to the use of alcohol, tobacco and 
drugs 
 Universal Prevention Curriculum, Coordinator Series, Course 5: School-
based Prevention Interventions (2015) 
 CICAD Hemispheric Guidelines on School Based Prevention 
 Canadian Standards for School-based Youth Substance Use Prevention 
Addressing individual psychological vulnerabilities 
Brief description 
Some personality traits such as sensation-seeking, impulsivity, anxiety 
sensitivity or hopelessness, are associated with increased risk of substance use. 
These indicated prevention programmes help these adolescents that are 
particularly at-risk deal constructively with emotions arising from their 
personalities, instead of using negative coping strategies including hazardous 
and harmful alcohol use. Therefore, they are mostly comprised of 
developmental components.  
Available evidence 
No new reviews were identified in the new overview of systematic reviews.  
In the first edition, two randomized control trials had reported effect with regard 
to this intervention in early adolescence and adolescence27 and one review had 
reported evidence with regard to this intervention in middle childhood28. 
With regard to primary outcomes, according to these studies, programmes 
addressing individual psychological vulnerabilities can lower the rates of 
drinking and binge-drinking at a two-year follow-up. 
                                            
 
27 Conrod (2008), Conrod (2010), Conrod (2011), Conrod (2013) and O'Leary-Barrett (2010) 
reporting on the same trial. 
28 Piquero (2010). 
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With regard to secondary outcomes, this type of intervention can impact 
individual mediating factors affecting substance use later in life, such as self-
control. 
The evidence originates all from Europe and North America.  
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Delivered by trained professionals (e.g. psychologist, teacher); 
 Participants have been identified as possessing specific personality traits on 
the basis of validated instruments; 
 Programmes are organised in such a way as to avoid any possible 
stigmatisation; 
 Provide participants with skills on how to positively cope with the emotions 
arising from their personality; 
 Short series of sessions (2-5). 
Mentoring 
Brief description 
“Natural” mentoring refers to the relationships and interactions between 
children/adolescents and non-related adults such as teachers, coaches and 
community leaders and it has been found to be linked to reduced rates of 
substance use and violence. These programmes match youth, especially from 
marginalised circumstances (selective prevention), with adults who commit to 
arrange for activities and spend some of their free time with the youth on a 
regular basis.  
Available evidence 
One systematic review reported findings with regard to this intervention29  
                                            
 
29 Thomas et al. (2013) 
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With regard to primary outcomes, this study provided some evidence of the 
effect of mentoring in preventing alcohol and drug use among youth.  
The evidence originated in the USA and Europe. 
WHO recommends mentoring as one of the interventions identified as 
evidence-based interventions to prevent youth violence30. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Provide adequate training and support to mentors; 
 Based on a very structured programme of activities. 
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4. Adolescence and adulthood 
As adolescents grow, interventions delivered in settings other than the family 
and the school, such as the workplace, the health sector, entertainment venues 
and the community, become more relevant.  
PLEASE NOTE. The evidence summarised for interventions and policies for 
early adolescents to be delivered in schools (i.e. preventive education, 
addressing individual vulnerabilities, school policies on substance use), as well 
as mentoring, report effectiveness also for older adolescents, without 
disaggregating the data by age groups. These interventions will not be 
discussed in this section again.  
Brief intervention 
Brief description 
Brief intervention consists of one-to-one counselling sessions that can include 
follow up sessions or additional information to take home. They can be 
delivered by a variety of trained health and social workers to people who might 
be at risk because of their substance use, but who would not necessarily seek 
treatment. The sessions first identify whether there is a substance use problem 
and provide immediate appropriate basic counselling and/or referral for 
additional treatment. The sessions are structured, and last typically from 5 to 
15 minutes. 
Brief intervention is typically delivered in the primary health care system or in 
emergency rooms, but it also has been found to be effective when delivered as 
part of school-based and workplace programs, and when delivered online or via 
computers.  
Brief intervention sessions typically employ motivational interviewing 
techniques, which is a psycho-social intervention where the substance use of a 
person is discussed and the patient is supported in making decisions and 
setting goals about his/her substance use. In this case, brief intervention is 
normally delivered over the course of up to 4 sessions that can be up to 1 hour 
long, but usually the sessions have shorter duration.  
35 
Available evidence 
Forty-eight reviews reported findings for this intervention31, thirty-eight of which 
from the new overview.  
With regard to the primary outcomes, these studies show that brief intervention 
and motivational interviewing may significantly reduce substance use. This 
evidence of effect was found regarding different substances (tobacco, alcohol 
and drugs) and different age groups (adolescents and adults), with effect sizes 
reported to be small and not to persist beyond 6-12 months.  
The reduction of excessive alcohol consumption among people with psychotic 
disorders was also reported. Indications of reduction in consumption of alcohol 
and/or harmful patterns of use were also reported both for youth out of college 
and in college.  
Within the school-based setting, one study concluded that there is limited 
quality evidence that brief school-based interventions were more effective in 
reducing substance use (tobacco, alcohol, drugs) than the assessment-only 
condition, and were similar to information provision. Other studies reported 
some effectiveness with regard to cannabis use and similar results to tobacco 
and alcohol.  
Computer- and internet-based delivery reported small effects that do not 
sustain in the long term (more than 12 months) for alcohol, with less evidence 
available with regard to tobacco and cannabis. One review reported 
effectiveness of interventions delivered through the telephone. Effect sizes 
were higher for delivery face-to-face.  
Review studying delivery in emergency settings noted that the integration of 
results was hampered by the heterogeneity of included studies on both 
adolescents and adults, alcohol and drugs. Effectiveness was noted, including 
for females and for patients qualifying for treatment.  
However, the interventions focusing on alcohol consumption primarily for 
adolescents and young adults may have limited evidence on tobacco use. The 
                                            
 
31 Ashton et al. (2015), Baker et al. (2012), Bertholet (2005), Carey et al. (2012), Carey et al. 
(2016), Carney (2012), Carney et al. (2014), Christakis (2003), Davis et al. (2017), Dedert et 
al. (2014), Dedert et al. (2015), Diestelkamp et al. (2016), Donoghue et al. (2014), Dotson et 
al. (2015), Dunn (2001), Elzerbi et al. (2015), Elzerbi et al. (2017), Foxcroft et al. (2015), 
Foxcroft et al. (2016), Gulliver et al. (2015), Hennessy & Tanner-Smith (2015), Hennessy et 
al. (2015), Jensen (2011), Jiang & Gao (2017), Kaner (2007), Kazemi et al. (2013), Landy et 
al. (2016), Leeman et al. (2015), McGinnes et al. (2016), Merz et al. (2015), Moreira (2009), 
Newton et al. (2013), Oosterveen et al. (2017), Park & Drake (2015), Peirson et al. (2016), 
Reavley (2010), Riper (2009), Riper et al. (2014), Scot-Sheldon et al. (2014), Scott-Sheldon 
et al. (2016), Smedslund (2011), Smedslund et al. (2017), Tait (2003), Tait et al. (2013), 
Vasilaki (2006), Watson et al. (2013), Wood et al. (2014), Young et al. (2014). 
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evidence for cannabis was reported to be scarce and inconclusive. Brief 
interventions and motivational interviewing benefit both adolescents and adults 
alike, however long-term impact on reducing alcohol use was less obvious. 
Moreover, the reduction of excessive alcohol consumption among people with 
psychotic disorders was also reported. 
WHO recommends screening and brief interventions for hazardous and harmful 
alcohol use in non-specialist health care settings, except in areas of low 
prevalence of alcohol use, where the screening of all patients may not be cost-
effective, but brief interventions can still be appropriate for identified drinkers. 
Screening for hazardous and harmful alcohol use should be conducted, using 
a validated instrument that can be easily incorporated into routine clinical 
practice (e.g. AUDIT, ASSIST). In settings in which screening is not feasible or 
affordable, practitioners should explore alcohol consumption in their patients 
when relevant. Patients with a hazardous and harmful alcohol use should 
receive a brief intervention. The brief intervention should comprise a single 
session of 5-30 minutes duration, incorporating individualised feedback and 
advice on reducing or ceasing alcohol consumption, and the offer of follow-up. 
Patients who on screening are identified as having alcohol dependence should 
be managed according to the existing WHO recommendations32.  
WHO recommends offering brief intervention to individuals using cannabis and 
psychostimulants, when they are detected in non-specialized health care 
settings (comprising a single session of 5-30 minutes duration, incorporating 
individualised feedback and advice on reducing or stopping cannabis / 
psychostimulant consumption, and the offer of follow-up). In addition, WHO 
recommends that people with ongoing problems related to their cannabis or 
psychostimulant drug use who does not respond to brief interventions should 
be considered for referral for specialist assessment33. 
WHO has developed the Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST) package to facilitate screening and brief interventions 
for all psychoactive substances including alcohol, tobacco and psychoactive 
drugs. The effectiveness of interventions was demonstrated in adults, and 
further work is required to establish effectiveness of ASSIST-based 
interventions among adolescents. 
                                            
 
32 WHO (2016), mhGAP Intervention Guide for mental, neurological and substance use 
disorders in non-specialized health settings. Version 2.0.  
33 WHO (2012), Brief psychosocial interventions, Evidence profile.  
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Existing guidelines and tools for further information 
 AUDIT - The Alcohol Use Disorders Identification Test: Guidelines for Use 
in Primary Care, Second Edition. WHO, 2001. 
 Brief Intervention for Hazardous and Harmful Drinking: A Manual for Use in 
Primary Care. WHO, 2001.  
 The Alcohol, Smoking and Substance Involvement Screening Test 
(ASSIST): Manual for use in primary care. WHO, 2010. 
 The ASSIST-linked brief intervention for hazardous and harmful substance 
use: Manual for use in primary care. WHO, 2010.  
 mhGAP Intervention Guide for mental, neurological and substance use 
disorders in non-specialized health settings. Version 2.0. WHO, 2016. 
Workplace prevention programmes 
Brief description 
The vast majority of substance use occurs among working adults. Substance 
use disorders expose employees to health risks and difficulties in their 
relationship with fellow employees, friends and family, as well as, more 
specifically to the workplace, to safety risks. Young adults are at particularly 
high risk, as job strain has been found to significantly increase the risk of 
developing substance use disorders among young adults using drugs. 
Employers also bear a significant cost of substance use. Employees with 
substance use problems have higher absenteeism rate and lower productivity, 
are more likely to cause accidents, and have higher health care costs and 
turnover rates. Moreover, employers have a duty to provide and maintain a safe 
and healthy workplace in accordance with the applicable law and regulations34. 
Prevention programmes in the workplace are typically multi-component, 
including prevention elements and policies, as well as counselling and referral 
to treatment. 
                                            
 
34 ILO (1996). Management of alcohol- and drug-related issues in the workplace. An ILO code 
of practice, Geneva, International Labour Office. 
38 
Available evidence 
Four (4) reviews reported findings with regard to this kind of intervention35, 2 of 
them from the new overview.  
With regard to primary outcomes, according to these studies, workplace 
prevention can prevent alcohol use with possible variability of effect across 
gender as one study reported a positive effect on reducing alcohol consumption 
amongst women, but not men. One review found no effect on the prevention of 
tobacco use.  
In addition, with regard to other health behaviours, another review indicated that 
workplace interventions may have a positive effect on physical fitness. The 
period for the sustainability of these results is not clear.  
Most of the evidence is from North America and Europe, with some research 
emerging from Australia and Asia. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Developed with the involvement of all stakeholders (employers, 
management, employees); 
 Guarantee confidentiality to employees; 
 Include and are based on a policy on substance use in the workplace that 
has been developed by all stakeholders and is non-punitive; 
 Provide brief intervention (including web-based), as well as counselling, 
referral to treatment and reintegration services to employees who need 
them; 
 Include a clear communication component; 
 Embedded in other health or wellness related programmes (e.g. for the 
prevention of cardiovascular diseases); 
 Include stress management courses; 
 Trains managers, employees and health workers in fulfilling their roles in the 
programme. 
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 Include alcohol and drug testing only as part of a comprehensive 
programme with the characteristics described in the above bullet points.  
Existing guidelines and tools for further information 
 Universal Prevention Curriculum, Coordinators’ Series, Course 6: 
Workplace-based Prevention Interventions (2015). 
 ILO (2012), SOLVE training package: Integrating health promotion into 
workplace OSH policies, Programme on Safety and Health at Work and the 
Environment (SAFEWORK), International Labour Organisation, Geneva, 
Switzerland. 
 CICAD (2009), CICAD Hemispheric Guidelines in Workplace Prevention. 
 UNODC in cooperation with ILO (forthcoming), Guidelines on workplace 
prevention programmes. 
Tobacco policies 
Brief description 
A series of policies to be delivered at the population level to reduce the 
availability and accessibility of tobacco and tobacco smoking.  
Available evidence 
Four (4) reviews reported findings about this kind of policies36, one (1) of which 
from the new overview, further supporting the WHO guidance provided below, 
particularly with regard to policies in work settings. 
The WHO Framework Convention on Tobacco Control stipulates clear 
evidence-based guidance with regard to strategies to reduce the demand of 
tobacco. These include price and tax measures, an effective and important 
means of reducing tobacco consumption by various segments of the 
population, in particular young persons. In addition, measures for the protection 
from exposure to tobacco smoke are also detailed, as scientific evidence has 
unequivocally established that exposure to tobacco smoke causes death, 
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disease and disability. Finally, additional regulation concerns the contents of 
tobacco products, the disclosures of tobacco product, the packaging and 
labelling of tobacco products, education, communication, training and public 
awareness, and, tobacco advertising, promotion and sponsorship. With regard 
to the latter, the Convention notes how a comprehensive ban on advertising, 
promotion and sponsorship would reduce the consumption of tobacco products. 
Existing guidelines and tools for further information 
 Reports and resources of the WHO Tobacco Free Initiative.  
Alcohol policies 
Brief description 
A series of policies and interventions to reduce the harmful use of alcohol 
defined as the drinking that causes detrimental health and social consequences 
for the drinker, the people around the drinker and society at large, as well as 
the patterns of drinking that are associated with increased risk of adverse health 
outcomes.  
Available evidence 
No new reviews were identified in the new overview of systematic reviews. 
The WHO Global Strategy to Reduce the Harmful Use of Alcohol37 of 2010 
summarizes clear evidence-based guidance with regard to interventions and 
policies in reducing the harmful use of alcohol, grouping them in 10 target areas. 
Besides leadership, awareness and commitment in protecting the population, 
responses are called for in the health sector, namely screening and brief 
intervention at primary health care and other settings, including for pregnant 
women and women of child bearing age. Another area of action concerns the 
mobilisation and empowering of communities in preventing the selling of alcohol 
to under-age drinkers and other at-risk groups and in developing alcohol-free 
environments and events. Drink-driving policies and countermeasures should 
be complemented by carefully planned, high-intensity, well-executed public 
awareness and information campaigns. Another crucial area of policy is the 
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regulation of the availability of alcohol through measures such as a licensing 
system on retail sales, or public health oriented government monopolies, 
regulating the number and location of on-premise and off-premise alcohol 
outlets, regulating days and hours of retail sales, regulating modes of retail 
sales of alcohol, regulating retail sales in certain places or during special 
events, establishing an appropriate minimum age for purchase or consumption 
of alcoholic beverages, and, adopting policies to prevent sales to intoxicated 
persons and to reduce the impact of marketing. It is particularly important to 
protect young people from the content of alcohol marketing, especially in low- 
and middle-income countries where adolescents have currently a low 
prevalence of alcohol consumption and are being targeted as new markets. In 
addition, increasing the price of alcoholic beverages through an effective and 
efficient system for taxation matched by adequate tax collection and 
enforcement is one of the most effective interventions to reduce harmful use of 
alcohol. Complementary policies include reducing the harm from alcohol 
intoxication and drinking without necessarily affecting the underlying alcohol 
consumption, particularly with regard to driving and enacting management 
policies relating to responsible serving of beverage on premises and training 
staff in relevant sectors in how better to prevent, identify and manage 
intoxicated and aggressive drinkers. Final areas of action are with regard to 
reducing the public health impact of illicit alcohol and informally produced 
alcohol, and, monitoring and surveillance.  
These policies are also recommended by WHO to prevent unintentional injury 
(road injury) amongst adolescents, youth violence and sexual and other forms 
of gender-based violence38, and child maltreatment39. 
Existing guidelines and tools for further information 
 Global Strategy to Reduce the Harmful Use of Alcohol. WHO, 2010.  
Community-based multi-component initiatives  
Brief description 
At the community level, mobilization efforts to create partnerships, task forces, 
coalitions, action groups, etc. bring together different actors in a community to 
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to Support Country Implementation. 
39 WHO (2016), INSPIRE: seven strategies for ending violence against children. 
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address substance use. Some community partnerships are spontaneous. 
However, the existence of community partnerships on a large scale is normally 
the product of a special programme providing financial and technical support to 
communities to deliver and sustain evidence based prevention interventions 
and policies over time. Community-based initiatives are normally multi-
component, taking action in different settings (e.g. schools, families, media, 
enforcement etc.). 
Available evidence 
No new reviews were identified in the new overview of systematic reviews.  
In the first edition, thirteen (13) reviews had reported findings with regard to this 
intervention40.  
With regard to primary outcomes, according to these studies, community-based 
multi-component initiatives can prevent the use of drugs, alcohol and tobacco.  
Although most evidence reported above originates from the USA/Canada, 
Europe, Australia, some few studies on community-based multi-component 
initiatives, particularly with regard to tobacco, originate from Asia. 
Mobilizing communities to prevent the selling of alcohol to, and consumption of 
alcohol by, under-age drinkers, and to develop and support alcohol-free 
environments, especially for youth and other at-risk groups is one of the areas 
of action identified as effective by the WHO Global Strategy to Reduce the 
Harmful Use of Alcohol.  
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Support the enforcement of tobacco and alcohol policies at the local level. 
 Work in a range of community settings (families and schools, workplace, 
entertainment venues, etc.) 
 Involve universities to support the implementation of evidence-based 
programmes and their monitoring and evaluation. 
                                            
 
40 Bühler (2008), Carson (2011), Carson (2012), Foxcroft (2011), Gates (2006), Jackson 
(2012), Jones (2006), Müller-Riemenschneider (2008), Roe (2005), Schröer-Günther (2011), 
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 Adequate training and resources are provided to the communities. 
 Initiatives are sustained in the medium term (e.g. longer than a year). 
Existing guidelines and tools for further information 
 CCSA (2010), Community-Based Standards, Canadian Standards for Youth 
Substance use Prevention, Canadian Centre on Substance use, Ottawa, 
Canada. 
Media campaigns 
Brief description 
Media campaigns are often the first and/or only intervention delivered by policy 
makers concerned with preventing the use of drugs in a population, as they are 
visible and have the potential to reach a large number of people relatively easily. 
Available evidence 
Six (6) reviews reported findings for this kind of intervention, 5 of them from the 
new overview41.  
With regard to primary outcomes, these studies reported contradictory findings 
on effect with regard to preventing tobacco, alcohol and drug use, with the 
exception of campaigns on tobacco in combination with other prevention 
components.  
The evidence reported originates from North America, Australia/ New Zealand 
and Europe. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Precisely identify the target group of the campaign. 
 Based on a solid theoretical basis. 
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 Design messages on the basis of strong formative research. 
 Strongly connect to other existing drug prevention programmes in the home, 
school, and community  
 Achieve adequate exposure of the target group for a long period of time. 
 Systematically evaluated. 
 Target parents, as this appears to have an independent effect also on the 
children.  
 Aim at changing cultural norms about substance use and/or educating about 
the consequences of substance use and/or suggesting strategies to resist 
substance use. 
Characteristics deemed to be associated with lack of efficacy and/or 
effectiveness or with adverse effects based on expert consultation 
 Media campaigns that are badly designed or poorly resourced should be 
avoided as they can worsen the situation by making the target group 
resistant to or dismissive of other interventions and policies. 
Entertainment venues 
Brief description 
Entertainment venues include bars, clubs, restaurants as well as outdoor or 
special settings where large-scale events may occur. These venues can have 
both positive and negative impact on the health and wellbeing of citizens, as 
they provide social meeting spaces and support the local economy, but at the 
same time, they are identified as high-risk settings for many risky behaviours, 
such as alcohol and drug use, drugged driving and aggression.  
Most prevention programmes utilizing entertainment venues have multiple 
components including different combinations of training of staff and managers 
and management of intoxicated patrons; changes in laws and policies, e.g. with 
regard to serving alcohol to minors or to intoxicated persons, or with regard to 
driving under influence of alcohol and/or drugs; high visibility enforcement of 
existing laws and policies; communication to raise awareness and acceptance 
of the programme and to change attitudes and norms; and, offering treatment 
to managers and staff. 
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Available evidence 
Three (3) reviews reported results with regard to this kind of interventions42, one 
(1) of which is from the new overview.  
With regard to primary outcomes, according to these studies, training of staff, 
policy interventions and enforcement reported some indication of effects on 
intoxication, risky alcohol consumption and alcohol-related harm, including in 
the context of sport events.  
All evidence originates from North America, Europe and Australia. 
Characteristics deemed to be associated with efficacy and/or effectiveness 
based on expert consultation 
 Trains staff and management on responsible serving and handling of 
intoxicated clients; 
 Provides counselling and treatment for staff and management who need it; 
 Includes a strong communication component to raise the awareness and 
the acceptance of the programme; 
 Includes the active participation of the law enforcement, health and social 
sectors; 
 Enforces existing laws and policies on substance use in the venues and in 
the community. 
Existing guidelines and tools for further information 
 UNODC, ATS prevention guide for policy makers. 
 CICAD report: Insights for a drugged driving policy. 
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II. Prevention issues requiring 
further research 
After-school activities, sports and other structured leisure time activities 
In many countries and communities, it is popular to organize sports and other 
drug- or substance-free leisure time activities as a way to give adolescents 
prosocial and healthy pursuits, preventing them from engaging in risky 
behaviours including drug use.  
The overview undertaken for this second updated edition of the Standards 
found one review studying informal education activities for positive youth 
development and reporting no effect or inconclusive outcomes.  
The review of literature undertaken for the first edition of the Standards had 
identified three reviews reporting practically no studies assessing the impact of 
organising sports on substance use or on mediating factors among children. 
The new overview did not identify new studies. In fact, it should be noted that 
participation in sports per se is not always associated with lower rates of 
substance use and that it has been linked to higher rates of smoking and binge 
drinking. 
The review of evidence that informed the WHO guidelines on preventing youth 
violence found that after-school and other structured extracurricular leisure time 
activities that included social skills training have resulted in reduced 
delinquency, reduced alcohol and drug use and decreased school dropouts. 
There was some evidence generated in low- and middle-income countries, but 
most studies have insufficiently robust research designs43 
It has been also reported that after-school programmes are frequently targeted 
at youths from poor socio-economic backgrounds or youths with behavioural 
problems, and several studies have noted that bringing together high-risk 
youths may have adverse effects. On the other hand, there exists examples of 
programmes where sport coaching is used as a setting to deliver personal and 
social skills education, one of which, Line Up Live Up, is being currently piloted 
by UNODC in Africa and Latin America.  
                                            
 
43 WHO (2015), Preventing youth violence; WHO (2017), Global Accelerated Action for the 
Health of Adolescents (AA-HA!) Guidance to Support Country Implementation. 
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In general, policy makers should exercise the utmost caution if choosing to 
implement this kind of intervention, including a strong research component to 
assess the impact.  
Preventing the non-medical use of prescription drugs 
The non-medical use of prescription drugs controlled under the Conventions is 
an increasing problem in many countries, so is the non-medical use of some 
medicines that are sold over-the-counter. In some countries, this challenge is 
second only to cannabis use. Although most notably visible in North America, 
there are reports of significant treatment demand in Europe, Africa, South Asia 
and Latin America. Depending on the country and the kind of substance, some 
more vulnerable groups (such as youth, women, older adults, health care 
professionals, but also street children and civilians and armed forces in post 
conflict situations) appear to be particularly at risk. Moreover, the health and 
social consequences of the non-medical use of prescription drugs can be as 
serious as for the use of other controlled drugs.  
The overview undertaken for this second updated edition of the Standards did 
not identify any systematic review with regard to preventing the non-medical 
use of prescription drugs specifically. However, it should be noted that most of 
the strategies that have been found to be effective in preventing substance use 
have strong developmental components and, as such, their effects are not 
specific to any particular substance and indeed are able to impact various risky 
behaviours. As such, there is emerging evidence that universal evidence-based 
interventions in schools, with families and in communities are effective in 
preventing the non-medical use of prescription drugs as well44. 
Sourcing of prescription drugs occurs through double doctoring, fraud, theft, 
and the Internet, as well as via family and friends. Therefore, in addition to these 
interventions, it may seem reasonable to assume that all of these sources 
present opportunities for prevention. There are some indications that providing 
guidelines and authoritative advice to physicians, as well as restricting and 
monitoring prescriptions and creating registers will change their prescribing 
behaviour and will limit the access of these medications only to the patients that 
needs them. Given the great influence of parents on youth, and given that many 
individuals report sourcing the substances from family, targeting parents to 
raise their awareness of the need to use prescription drugs only under medical 
supervision, both for themselves and their children, might be a promising 
approach. Practical steps in the community to safely dispose of prescription 
drugs that are out-dated or no longer being used by the intended recipient might 
be promising. Finally, health-care professionals might need to be trained on an 
                                            
 
44 Spoth et al. (2017), Spoth et al. (2016), Spoth et al. (2013).  
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ongoing basis on how to prevent, recognize and manage the non-medical use 
of prescription drugs and related consequences45. 
Some additional indications on possible interventions and policies to prevent 
the non-medical use of prescription drugs can be found at UNODC (2011), The 
non-medical use of prescription drugs, policy direction issues, United Nations 
Office on Drugs and Crime, Vienna, Austria and CICAD (2012), Guide to 
preventing prescription drug abuse, Inter-American Drug Abuse Control 
Commission, Washington D.C., USA. 
Interventions and policies targeting children and youth particularly at risk 
The overview undertaken for this second updated edition of the Standards did 
not identify any systematic review with regard to preventing substance use 
among children and youth particularly at risk, in spite of evidence indicating that 
they are often exposed to drugs at a very young age. This group includes, for 
example, out-of-school children and youth, street children, current and ex-child 
soldiers, children and youth of displaced or post-conflict populations, children 
and youth in foster care, in orphanages and in the juvenile justice system.  
Prevention of the use of new psychoactive substances not controlled under 
the Conventions 
Many countries have witnessed the recent rise of the use of new psychoactive 
substances that are not controlled under the Conventions (the so called ‘legal 
highs’, or ‘smart drugs’)46. The overview undertaken for this second updated 
edition of the Standards did not identify any systematic review with regard to 
the prevention of such substances. However, it should be noted that, as in the 
case of the non-medical use of prescription drugs, most prevention strategies 
based on scientific evidence are not substance specific. This is particularly true 
of strategies that address vulnerabilities early in life or that strengthen positive 
coping skills to prevent the resort to negative coping skills, including substance 
use. Therefore, it appears to be reasonable to consider that such strategies 
might be also effective in preventing the use of these new psychoactive 
                                            
 
45 From the draft version of The Surgeon General’s Call to Action to Prevent Prescription Drug 
Abuse Among Youth: The Dangers of Improper Use of Controlled Medications, 2014 
(unpublished) and UNODC (2011), The non-medical use of prescription drugs, policy direction 
issues, United Nations Office on Drugs and Crime, Vienna, Austria.  
46 UNODC (2017), World Drug Report, United Nations Office on Drugs and Crime, Vienna, 
Austria.  
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substances. However, this is another area were rigorous research would 
appear to be necessary.  
The influence of media 
Exposure to media exerts a profound influence on the psychosocial 
development of young people. In particular, popular culture (e.g. celebrities, film, 
music) can strongly influence the initiation of risky behaviours such as alcohol 
and tobacco use. Several potential mechanisms may explain this influence, 
including a desire to acquire the traits that make celebrities special or the 
spread of behaviours throughout social networks. Due to the unique 
neurodevelopmental context of young people, they are particularly susceptible 
to the influence of popular culture and their actions are not simply a result of 
health illiteracy. Although this topic is not covered in this document, further 
research to examine the issue more closely would be warranted. In addition, 
and with reference to the relevant section in the previous chapter, it should be 
noted that the evidence available on the effectiveness of mass media 
campaigns is extremely limited. In this context, more research on the 
effectiveness of mass media campaign is imperative. 
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III. Characteristics of an 
effective prevention system 
An effective national drug prevention system delivers an integrated range of 
interventions and policies based on scientific evidence, in multiple settings, 
targeting relevant ages and levels of risk. This should come as no surprise given 
the complex interplay of factors that make children, youth and adults alike, 
vulnerable to substance use and other risky behaviours. It is not possible to 
address such vulnerabilities by simply implementing a single prevention 
intervention that is often isolated and limited in its timeframe and reach. The 
overarching goal here is to support the healthy and safe development of 
individuals. Arguably, an effective prevention system would comprise strategies 
with a mix of environmental and developmental components, with a minor 
component focusing on information. 
To deliver an integrated range of interventions and policies, a system requires 
strong structural foundations, which are briefly described in this section and 
include:  
 A supportive policy and legal framework; 
 Scientific evidence and research 
 Coordination of multiple sectors and levels (national, sub-national and 
municipal/ local) involved; 
 Training of policy makers and practitioners; and, 
 Commitment to provide adequate resources and to sustain the system in 
the long term. 
1. Range of interventions and policies based on 
evidence 
The previous section has provided a comprehensive review of the interventions 
and policies that have been found to be efficacious or effective in preventing 
substance use. Strategies differ in four main areas: the age of the target group, 
the level of risk of the target group, the setting in which the strategy is delivered, 
and the focus of action (environmental, developmental, information). An 
effective system delivers a range of evidence based interventions and policies 
in order to: 
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 Support children and youth throughout their development and particularly at 
critical transition periods where they are most vulnerable, e.g. infancy and 
early childhood, at the transition between childhood and adolescence. 
 Target the population at large (universal prevention), but also support 
groups (selective prevention) and individuals (indicated prevention) that are 
particularly at risk.  
 Address both individual and environmental factors of vulnerability and 
resilience. 
 Reach the population through multiple settings (e.g. families, schools, 
communities, the workplace, etc.) 
2. Supportive policy and regulatory framework 
No programme, no policy can exist in a vacuum. As noted in the introduction, 
drug prevention is but one of the fundamental components of a health-centred 
system focused on ensuring that drugs are available for medical and research 
purposes whilst preventing diversion and drug use and that other psychoactive 
substances do not impact on the burden of health. In this respect, an effective 
national system would be: 
 Embedded in comprehensive and health-centred system of drug control 
focused on ensuring the availability of drugs for medical and research 
purposes, whilst preventing diversion and drug use, thus including supply 
reduction, treatment, care and rehabilitation of drug dependence, and, 
prevention of the health and social consequences of drug use (e.g. 
HIV/AIDS, hepatitis C, drug overdose, driving under the influence, etc.). 
 Based on the understanding of drug use disorders as health conditions 
developing as a result of a complex interaction of genetic, biological and 
psychological factors with the environment and they need to be treated and 
not punished. 
 Linked to a public health national strategy for the healthy and safe 
development of children, youth and adults, including the prevention, 
treatment and care for substance use disorders, as well as the prevention 
of other unhealthy or risky behaviours. 
In addition, there are important societal characteristics that have great impact 
on the implementation and effectiveness of evidence-based prevention, such 
as the degree of inequality, of social capital and of social norms with regard to 
the use of psychoactive substances.  
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Moreover, the delivery of programmes by both governmental and non-
governmental agencies can be greatly enhanced if it is mandated and 
supported at the national level by appropriate regulation, including: 
 National standards, including quality standards, for drug prevention 
interventions and policies; in addition to these Standards, the European 
Drug Prevention Quality Standards were developed by a consortium of 
research and practice institutions in Europe and have developed useful 
Toolkits, including: for the policy maker that wants to fund quality prevention 
strategies (Toolkit 1), for the practitioner that wants to undertake a self-
assessment with a view to improvement (Toolkit 2) and for national groups 
who want to rigorously adapt the European Standards (Toolkit 4); training 
materials (Toolkit 3) are also available; the portfolio of Standards of the 
Canadian Centre on Substance Abuse are also an important example; 
 It is suggested that, to the extent possible, national standards enforce a 
requirement of implementing evidence-based strategies only; one way of 
supporting this is to create a registry of evidence-based strategies or make 
reference to existing registries such as “Blueprints for Healthy Youth 
Development” and those developed in many European countries, with 
“Xchange”, a unified European registry being currently piloted and available 
by the EMCDDA. 
 National professional standards for drug prevention policy makers and 
practitioners, possibly within an accreditation system; an accreditation 
system would also support the professionalization of the field and the 
creation of organisations of professionals, much as it happens already in the 
field of treatment of drug use disorders; a global pilot experience in this 
sense that can provide useful support is the International Society of 
Substance Use Professionals (ISSUP).  
 A policy requiring schools to implement evidence-based substance use 
prevention programmes and policies in the context of health or personal/ 
social education and promotion, including standards on how to do so; 
 A policy requiring employers to implement substance use workplace 
prevention policies or programmes, including standards on how to do so; 
 A policy requiring health, social and education services to support families 
to nurture the physical, cognitive and emotional development of their 
children. 
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3. A strong basis on research and scientific 
evidence 
An effective national drug prevention system should both be based on scientific 
evidence and support research efforts to contribute to the evidence base. There 
are two dimensions to this. On the one hand, interventions and policies should 
be chosen based on an accurate understanding of what the situation really is. 
This systemic approach will include identifying the population that is most 
vulnerable or starting to use psychoactive substances, possible reason for why 
they are initiating use, and which interventions and policies most closely 
respond to this situation. On the other hand, the effectiveness and, whenever 
possible, the cost effectiveness of delivered interventions and policies, needs 
to be rigorously evaluated. Results of this rigorous evaluation will allow 
decision-makers to know the impact on outcomes such as decrease in initiation 
of drug use and to inform and expand the base of knowledge related to 
prevention interventions. It is also important that this research and its findings 
be peer-reviewed, published, and discussed to the extent possible. 
Evidence-based planning 
With regard to the first dimension, an information system should be in place to 
provide the necessary understanding of the situation, as well as opportunities 
to use this knowledge to plan. To address this dimension, an effective national 
prevention system would include: 
 An information system regularly collecting and monitoring information on: 
 Prevalence: What percentages of people (by age, gender, and other 
important characteristic) are using which substance(s)? How often and 
how much? What are the health and social consequences? 
 Initiation of drug use: at what age are people (especially young people) 
initiating to use drugs and/other substances?  
 Vulnerabilities: Why are people, especially young people, initiating to use 
drugs and/or of other substances? What is the situation among children 
with regard to factors that are known to be linked to substance use (e.g. 
poor parenting,, poor attachment to school, violence and abuse, etc.)?  
 A formal mechanism to regularly feed the data generated by the information 
system into a systemic planning process that will in turn consider: 
 Strategies needed: which evidence-based interventions and policies 
have been effective to address the identified situation? 
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 Availability and coverage of existing strategies: Which of these 
interventions and policies are currently being implemented? What 
percentage of the population who need them are reached by these 
interventions and policies?  
 Quality of existing strategies: Are ongoing interventions and policies 
based on scientific evidence (this refers to both the scientific 
understanding of the vulnerabilities addressed and/or the systematic 
adaptation of existing evidence-based programmes)?  
 Effectiveness of existing strategies: Have the strategies been evaluated 
(see below) and, if so, what are the results? What do the data generated 
by the information system tell us with regard to the effectiveness of the 
prevention system as whole? 
 Available infrastructures and resources that could be utilised as part of 
the national prevention system: which institutions do or should 
implement prevention? Is the funding centralised or decentralised? How 
is the funding allocated?  
 What are the gaps between the strategies needed and the availability, 
coverage, quality and effectiveness of the existing systemic strategies, 
infrastructures and resources?  
Research and planning 
The second dimension pertains to the evaluation of specific prevention 
programmes and policies. As noted, evidence based strategies identified in the 
previous section are not necessarily appropriate to the target, to the level of 
resources, or to the cultural environment, although in many cases they will be. 
There may be other programmes or policies that more successfully address 
these issues. It is imperative that selected programmes and policies are:  
 Based on a scientific understanding of the vulnerabilities addressed. In other 
words, and as an example, it is strongly desirable that programmes and 
policies are created to address a risk factor or situation that has been found 
to be linked to increased initiation (or earlier onset or higher prevalence of 
substance use) by scientific research and a needs assessment, not by the 
feelings of an individual, however well-intentioned and concerned.  
 Include a scientific monitoring and evaluation component in order to assess 
whether these interventions result in the desired outcome. This implies 
strong collaboration with academic and research institutions (including, but 
not limited to, universities), as well as the use of experimental or quasi 
experimental design. In the field of medicine, no intervention would be 
normally used unless scientific research had found it to be effective and safe. 
The same should go for drug prevention interventions.  
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It should be noted that in the Standards, the intention was to provide an 
indication of the effectiveness, or at least the efficacy, of kinds of interventions 
and policies, without referring to specific evidence-based programmes. 
However, the evidence originates in the evaluation of specific programmes and 
this means that it can never be assumed that a strategy that is ‘basically similar’ 
to an evidence-based one will be as effective. For example, while there may be 
evidence for “prenatal and infancy visitation programmes” overall, some 
particular ones of that type are quite effective and other particular ones of that 
type have been shown to be ineffective, even though they may have some of 
the characteristics that have been deemed to be associated with efficacy and/or 
effectiveness. This is another reason why evaluation becomes so crucial.  
The Canadian Centre on Substance Abuse has developed useful tools to 
support the monitoring and evaluation of prevention, and UNODC has 
developed a training for policy makers on supporting a culture of evaluation of 
prevention. Finally, Course 3 of the Coordinator Series of the Universal 
Prevention Curriculum is entirely dedicated to Monitoring and Evaluation. 
Also in the case of the implementation of an evidence-based programme, 
monitoring and evaluation remain extremely important in the context of a careful 
adaptation of the programme. In this case, it is suggested that the process 
includes: 
 A careful and systematic process of adaptation that does not touch the core 
components of the programme, while making it more acceptable to the new 
socio-economic/ cultural context. Ideally, this would take place with the 
support of the developers of the programme. In this context, the UNODC 
Guide on family skills training contains a chapter solely devoted to 
adaptation, whilst Toolkit 4 of the European Drug Prevention Quality 
Standards has developed a careful and detail process for national 
stakeholders that want to adapt and adopt the Standards and that would be 
extremely useful also in this respect; 
 A scientific monitoring and evaluation component in order to assess whether 
the programme is actually effective in the new socio-economic/ cultural 
context. Whilst a control component would be preferable (and possibly 
randomised), particularly at the stage of piloting a pre- and post-collection 
of data comparing to the original study would already provide a good 
indication of whether the programme is working in the new context or not; 
an additional advantage of evidence-based programmes is that all the 
monitoring and evaluation instruments are already available.  
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4. Different sectors involved at different levels 
National drug prevention systems are about ensuring children, youth and adults 
have the opportunity to lead healthy and safe lifestyles in multiple settings. 
Therefore, the national sectors to be involved in the delivery of systemic 
prevention interventions and policies are many and necessitate clear role 
definition and coordination.  
A national drug prevention system would therefore involve relevant national 
sectors (e.g. education, health, social welfare, youth, labour, law enforcement, 
etc.) in the planning, delivery, monitoring and evaluation of its components: 
 Integrated levels of consistent implementation: national (federal), sub-
national (state/regional/district), and municipal, local). 
 Full spectrum of key stakeholders. This could include, but is not limited to: 
national and sub-national administration, municipal or local, governmental 
service delivery agencies, non-governmental agencies, residents and 
community leaders, religious communities and leaders, universities and 
other research institutions, and the private sector, as appropriate. 
 Structured and well-defined roles and responsibilities for all stakeholders: 
there is great value in a partnership and collaboration of various 
stakeholders working together and taking responsibility for different 
elements of policy development and implementation. 
 A clear mechanism to provide decision-makers (whether centralised or 
decentralised) with strong technical assistance to guide them in 
implementing evidence-based policies and interventions.  
 A strong lead and coordinating agency. 
It should be noted that there is not one single way of organising the delivery of 
evidence-based prevention strategies. For example, they need not necessarily 
be carried out in the form of programmes, but can also be integrated into the 
everyday work of institutions and services such as the school, youth work and 
health and social services. In this case, strategies are planned, managed and 
coordinated centrally, while the implementation relies on local multi-
professional co-ordination. Other possible examples of how different levels 
could interact would include: 
 Policy makers at the national level coordinate the development of the 
national policies, set the quality standards and support the infrastructure for 
implementation through adequate funding for the delivery of strategies and 
for the training for relevant stakeholders. 
 Policy makers and/or agencies at the local level deliver interventions and 
policies, feed data to the information system, and actively improve their 
knowledge and skills. 
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 NGOs, residents and community leaders (which could include religious 
communities and leaders) mobilize for changes in or acceptance of policies, 
influencing community norms, delivering evidence-based interventions and 
policies; it should be noted that community mobilization has been found to 
be an effective and participatory mechanism to realize evidence-based 
strategies.  
 Universities and research institutions analysing data to feed a better 
understanding of the substance use situation and to monitor and evaluate 
the national policies, evaluating specific interventions and policies.  
 Private sector actively supporting prevention in the workplace and 
contributing, as appropriate, to evidence-based and innovative interventions. 
5. Strong infrastructure of the delivery system 
To be delivered effectively, interventions and policies must be supported by 
adequate resources. 
 Agencies delivering interventions and policies need to be adequately 
financed.  
 Practitioners delivering intervention and policies need to be adequately 
trained on an ongoing basis; the Coordinator Series of the Universal 
Prevention Curriculum has been developed and piloted globally with an 
European adaptation, UPC-Adapt ongoing. It comprises nine courses 
providing a foundation and a complete overview of the evidence-based 
practice. A second series for Implementers is currently under development.  
 Policy makers at different levels of planning and developing interventions 
and enforcing policies need to be adequately trained on an ongoing basis. 
 Technical assistance should be provided on an on-going basis to support 
implementation and continuous quality improvements. 
 Academic and research institutions need to be adequately financed by 
supporting scientific monitoring and evaluation as part of the implementation 
of prevention.  
58 
6.  Sustainability 
Drug prevention is effective and cost-effective, but, as with all policies, there 
needs to be a visible medium- to long-term investment to realize its potential. 
In this respect, the following are the ways in which the action of the components 
mentioned above should be sustained:  
 A mechanism of review and adjustment of the national prevention system at 
regular intervals;  
 Delivery of evidence-based interventions and policies planned and 
resourced to be active at least in the medium term; 
 Regular collection of data through the information system, including 
feedback into the planning/ review process; 
 Continuous support to research for the rigorous evaluation of interventions 
and policies; 
 Continuous support to the training of practitioners and policy makers 
involved in the planning, delivery, monitoring and evaluation of drug 
prevention strategies.  
59 
Figure 1 – Schematic representation of a national drug prevention system 
  
